Monomeric and Oligomeric Decorsins of the Asian Medicinal Leech
Tolksdorf C, Wolf R, Rauch BH, Jedlitschky G, Müller C (2025) · International Journal of Molecular Sciences · n=0
Study Profile
- Design
- molecular biology, recombinant protein expression, and platelet aggregation functional study of decorsins encoded in the Hirudinaria manillensis (Asian buffalo leech) genome (Pharmacology and Toxicology, University Medicine Oldenburg and University Medicine Greifswald, Germany)
- Sample size (n)
- 0
- Intervention
- Identification of one monomeric and four multimeric decorsin-encoding genes in the H. manillensis genome; recombinant expression, purification, and functional characterization of selected putative decorsins for platelet aggregation inhibition
- Comparator
- Cross-leech-species comparison with hirudin gene family and prior decorsin literature
- Primary endpoint
- Identification of decorsin-encoding genes; platelet-aggregation-inhibitory potency of recombinant decorsins; mathematical demonstration of alternative pre-mRNA splicing potential for combinatorial factor generation
- Primary result
- Five decorsin-encoding genes identified (one monomeric, four multimeric); all but one of the recombinant decorsins displayed platelet aggregation-inhibitory potency; mathematical analysis based on alternative pre-mRNA splicing demonstrates potential to generate enormous combinatorial diversity from a single multimeric ornatin gene; H. manillensis genome thus encodes both anticoagulant (hirudin) and antiplatelet (decorsin) factor families
- Follow-up duration
- not applicable (genomic and recombinant-protein mechanism study)
- PMID
- 41303498
Key Findings
- First systematic identification of decorsin-encoding genes (one monomeric, four multimeric) in the Asian buffalo leech (Hirudinaria manillensis) genome
- Recombinant expression confirms platelet aggregation-inhibitory function for most decorsin variants
- Mathematical analysis of alternative pre-mRNA splicing demonstrates large combinatorial diversity potential from a single multimeric ornatin gene
- Extends the leech-pharmacology landscape from anticoagulants (hirudins, HLFs) to antiplatelet agents (decorsins, ornatins)
- Asian medicinal leech species adds geographic and molecular diversity to the predominantly European hirudin-focused literature
Limitations
- Mechanistic genomic and recombinant-protein study only - no clinical or in vivo data
- Functional characterization limited to selected representative recombinant proteins
- Platelet aggregation inhibition demonstrated in vitro; pharmacokinetics and bioavailability untested
- Genome data interpretation depends on assembly quality and annotation completeness
- Asian buffalo leech is not the principal commercial therapeutic species in the US or Europe
Clinical Implications
Tolksdorf 2025 expands the molecular pharmacology of medicinal leeches by characterizing decorsins, a family of antiplatelet factors distinct from the well-known hirudin anticoagulants. For ASH editorial purposes, the trial supports compound-registry pages that distinguish the multiple parallel mechanisms by which leech saliva contributes to hemostasis modulation. For US clinicians, the trial does not change practice but does provide important mechanistic context for understanding why whole-leech therapy produces a broader hemostatic effect than purified hirudin alone. The trial is cited as foundational mechanism literature alongside Müller 2016 and Wang 2018.
Related Trials
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)